Circulating vitamin D concentrations and the risk of urticaria: A bidirectional two-sample Mendelian randomization study.

IF 1.5 4区 医学 Q4 NUTRITION & DIETETICS
Hai-Xia Chai, Feng Wang, Hui Liu, Yu-Qing Xie, Zhi-Heng Zhou
{"title":"Circulating vitamin D concentrations and the risk of urticaria: A bidirectional two-sample Mendelian randomization study.","authors":"Hai-Xia Chai, Feng Wang, Hui Liu, Yu-Qing Xie, Zhi-Heng Zhou","doi":"10.6133/apjcn.202510_34(5).0004","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Vitamin D deficiency has been linked to urticaria, but causality remains uncer-tain. We used Mendelian randomization (MR) to investigate potential causal effects of vitamin D and its me-tabolites on urticaria risk.</p><p><strong>Methods and study design: </strong>Summary statistics from genome-wide association studies (GWAS) of total 25-hydroxyvitamin D [25(OH)D] (n=120,618), 25-hydroxyvitamin D3 [25(OH)D3] (n=40,562), and C3-epimer-25-hydroxyvitamin D3 [C3-epi-25(OH)D3] (n=40,562) in Europeans were used, along with data on urticaria and its subtypes from FinnGen consortium (R10 release). For validation, we performed additional MR analyses using a larger dataset that meta-analyzed data from the UK Biobank and GWAS results from the SUNLIGHT consortium (n=496,946) as exposure variables. We performed compre-hensive sensitivity analyses, including heterogeneity tests, pleiotropy assessments, and leave-one-out analyses to evaluate result robustness. Statistical power calculations were conducted to validate the reliability of our findings.</p><p><strong>Results: </strong>MR analysis revealed a causal protective effect of higher total 25(OH)D levels on urticaria risk [odds ratio (OR) = 0.81, 95% confidence interval (CI):0.69-0.95, p =0.008, statistical power = 81.1%]. Similar causal effects were observed for 25(OH)D3 levels (OR = 0.85, 95% CI: 0.74-0.98, p = 0.023, statistical power = 67.4%).These findings were validated in the replication cohort using serum 25(OH)D measurements (OR = 0.69, 95%CI: 0.56-0.85, p = 0.001, statistical power = 96.1%). Sensitivity analyses showed no significant heterogeneity or pleiotropy. Reverse MR analysis found no evidence that genetic risk of urticaria affects vitamin D levels, suggesting a potentially unidirectional causal relationship.</p><p><strong>Conclusions: </strong>This study provides the first genetic evidence that higher vitamin D levels may reduce urticaria risk, offering a new theoretical basis for urticaria prevention and treatment strategies.</p>","PeriodicalId":8486,"journal":{"name":"Asia Pacific journal of clinical nutrition","volume":"34 5","pages":"740-749"},"PeriodicalIF":1.5000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12490950/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asia Pacific journal of clinical nutrition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.6133/apjcn.202510_34(5).0004","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"NUTRITION & DIETETICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background and objectives: Vitamin D deficiency has been linked to urticaria, but causality remains uncer-tain. We used Mendelian randomization (MR) to investigate potential causal effects of vitamin D and its me-tabolites on urticaria risk.

Methods and study design: Summary statistics from genome-wide association studies (GWAS) of total 25-hydroxyvitamin D [25(OH)D] (n=120,618), 25-hydroxyvitamin D3 [25(OH)D3] (n=40,562), and C3-epimer-25-hydroxyvitamin D3 [C3-epi-25(OH)D3] (n=40,562) in Europeans were used, along with data on urticaria and its subtypes from FinnGen consortium (R10 release). For validation, we performed additional MR analyses using a larger dataset that meta-analyzed data from the UK Biobank and GWAS results from the SUNLIGHT consortium (n=496,946) as exposure variables. We performed compre-hensive sensitivity analyses, including heterogeneity tests, pleiotropy assessments, and leave-one-out analyses to evaluate result robustness. Statistical power calculations were conducted to validate the reliability of our findings.

Results: MR analysis revealed a causal protective effect of higher total 25(OH)D levels on urticaria risk [odds ratio (OR) = 0.81, 95% confidence interval (CI):0.69-0.95, p =0.008, statistical power = 81.1%]. Similar causal effects were observed for 25(OH)D3 levels (OR = 0.85, 95% CI: 0.74-0.98, p = 0.023, statistical power = 67.4%).These findings were validated in the replication cohort using serum 25(OH)D measurements (OR = 0.69, 95%CI: 0.56-0.85, p = 0.001, statistical power = 96.1%). Sensitivity analyses showed no significant heterogeneity or pleiotropy. Reverse MR analysis found no evidence that genetic risk of urticaria affects vitamin D levels, suggesting a potentially unidirectional causal relationship.

Conclusions: This study provides the first genetic evidence that higher vitamin D levels may reduce urticaria risk, offering a new theoretical basis for urticaria prevention and treatment strategies.

循环维生素D浓度与荨麻疹风险:一项双向双样本孟德尔随机研究。
背景和目的:维生素D缺乏与荨麻疹有关,但因果关系尚不清楚。我们使用孟德尔随机化(MR)来研究维生素D及其代谢产物对荨麻疹风险的潜在因果影响。方法和研究设计:使用欧洲人全基因组关联研究(GWAS)总25-羟基维生素D [25(OH)D] (n=120,618)、25-羟基维生素D3 [25(OH)D3] (n=40,562)和c3 -epimer-25-羟基维生素D3 [C3-epi-25(OH)D3] (n=40,562)的汇总统计数据,以及FinnGen联盟(R10发布)的荨麻疹及其亚型数据。为了验证,我们使用一个更大的数据集进行了额外的MR分析,该数据集荟萃分析了来自UK Biobank的数据和来自SUNLIGHT联盟的GWAS结果(n=496,946)作为暴露变量。我们进行了综合敏感性分析,包括异质性检验、多效性评估和遗漏分析,以评估结果的稳健性。统计功率计算进行验证我们的研究结果的可靠性。结果:MR分析显示较高的总25(OH)D水平对荨麻疹风险有因果保护作用[优势比(OR) = 0.81, 95%可信区间(CI):0.69-0.95, p =0.008,统计能力= 81.1%]。在25(OH)D3水平中观察到类似的因果效应(OR = 0.85, 95% CI: 0.74-0.98, p = 0.023,统计能力= 67.4%)。在重复队列中,使用血清25(OH)D测量验证了这些发现(OR = 0.69, 95%CI: 0.56-0.85, p = 0.001,统计能力= 96.1%)。敏感性分析显示没有显著的异质性或多效性。反向磁共振分析发现,没有证据表明荨麻疹的遗传风险会影响维生素D水平,这表明存在潜在的单向因果关系。结论:本研究首次提供了高水平维生素D可降低荨麻疹风险的遗传学证据,为制定荨麻疹防治策略提供了新的理论依据。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.70%
发文量
58
审稿时长
6-12 weeks
期刊介绍: The aims of the Asia Pacific Journal of Clinical Nutrition (APJCN) are to publish high quality clinical nutrition relevant research findings which can build the capacity of clinical nutritionists in the region and enhance the practice of human nutrition and related disciplines for health promotion and disease prevention. APJCN will publish original research reports, reviews, short communications and case reports. News, book reviews and other items will also be included. The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer-reviewed by at least two anonymous reviewers and the Editor. The Editorial Board reserves the right to refuse any material for publication and advises that authors should retain copies of submitted manuscripts and correspondence as material cannot be returned. Final acceptance or rejection rests with the Editorial Board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信